Advertisement
Vonvendi has been approved by the U.S. Food and Drug Administration to treat adults with von Willebrand disease.

FDA Approves Vonvendi to Treat von Willebrand Disease

0
Approved for the as-needed treatment and control of bleeding episodes in adults
Statin treatment is associated with reduced risk of incident cataract development

Statin Treatment Linked to Reduced Risk of Cataracts

0
Simvastatin plus ezetimibe linked to lower risk of cataract development versus placebo
The prices of cancer drugs vary greatly across high-income countries

Variation in Prices of Cancer Drugs in High-Income Countries

0
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
For patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma

ASH: Ibrutinib Bests Chlorambucil in Chronic Lymphocytic Leukemia

0
Improvements in progression-free survival, overall survival, response rate for ibrutinib
Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment

Etiology of Leukemia in Breast Cancer Survivors Explored

0
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
Breast cancer survivors who take antidepressants while on tamoxifen are not at increased risk for cancer recurrence

Antidepressants Don’t Adversely Affect Tamoxifen Efficacy

0
No greater risk of breast cancer recurrence seen
Metformin appears to trigger favorable changes in intestinal bacteria

Metformin Linked to Beneficial Changes in Gut Bacteria

0
Drug tied to increased bacteria which produce health-promoting short-chain fatty acids
For patients with Duchenne muscular dystrophy

IV Bisphosphonate Tx Linked to Drop in Bone Turnover in DMD

0
Need for therapies with less bone turnover suppression in Duchenne muscular dystrophy
For men with type 2 diabetes and hypogonadotropic hypogonadism

Testosterone Treatment Tied to Improved Insulin Sensitivity

0
Increased insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism
Nearly half of American adults who should be taking cholesterol-lowering drugs don't

CDC: Too Few Taking Needed Cholesterol-Lowering Drugs

0
Only half who should are using medications to help prevent cardiovascular disease